-
While women wait for a decision from the Food and Drug Administration (FDA) on the status of moving emergency contraception over the counter (OTC), some family planning providers are looking at using the telephone and Internet to help expand access to the method.
-
Call it "crystal," "tina," or "crank," use of crystal methamphetamine is cutting across all socioeconomic and sexual boundaries. How does that affect your family planning facility?
-
Early research in rhesus monkeys indicates that a combination of two AIDS treatment drugs, tenofovir (TDF, Viread, Gilead; Foster City, CA) and emtricitabine (FTC, Emtriva; Gilead), may be effective in HIV prevention.
-
When it comes to sexually transmitted diseases (STDs), new data released by the American Social Health Association (ASHA) in Research Triangle Park, NC, shows that the average age of people who are tested for chlamydia is 28.9 for women and 30.5 for men.
-
The Food and Drug Administration (FDA) has ruled out mifepristone (Mifeprex, Danco Laboratories, New York City) as the cause in one of two recent deaths of women who had taken the drug. The agency is continuing to investigate the other death.
-
Check the chart of your next patient. She says she has vaginal itching and irritation, odor, and vaginal discharge. What is your next step?
-
A new patient tells you that she is a recent victim of sexual assault. What care was she provided when she underwent treatment at your local hospital's emergency department (ED)?
-
Felicia Hance Stewart, MD, co-author of Contraceptive Technology and member of the Contraceptive Technology Update Editorial Board, died April 12 of lung cancer at her home in San Carlos, CA.
-
It has been two years since a "black box" warning was added to the labeling for the contraceptive injection depot medroxyprogesterone acetate.
-
A recent survey of 100 public and private colleges found that many facilities may not be making the grade when it comes to providing condom availability and sexual health information.
